Bettina Thiel

Bettina Thiel serves as a Senior Therapeutic Medical Scientist at Cytokinetics since October 2025, following a tenure at Jazz Pharmaceuticals as a Senior Medical Science Liaison, focusing on rare disease epilepsy within neuroscience from February 2021 to October 2025. Previously, Bettina held positions as Medical Science Liaison Manager and Medical Science Liaison at Teva Pharmaceuticals, and worked in sales and implementation of molecular diagnostics at bioMérieux. Bettina's career also includes a role as Vertriebsexperte at MSD Sharp & Dohme GmbH, where responsibilities encompassed specialization in anesthesia with a focus on a new class of muscle relaxant reversal drugs. Earlier experience includes administrative duties at the University Hospital Schleswig-Holstein, where Bettina managed a project on noninvasive prenatal diagnostics, and research and development expertise at UKE, contributing significantly to various healthcare initiatives. Bettina holds a Diplom-Ingenieurin degree in Technical Chemistry from Technische Hochschule Lübeck.